PatternsRadar
Sign in

HEALTHXHealth X Platform Limited

NSE
Full chart
284.95INR+7.95 (+2.87%)Close · 6 Oct 2026
7 Aug 2026Last results
HealthcareSector
Healthcare ServicesIndustry
₹906 CrMarket cap
—P/E (TTM)
93.2%Delivery

Filings & corporate actions

68 results filed
CSV
Next results · Q2 FY27
Expected 11 Nov 2026 – 15 Nov 2026
Estimate: filed 42–46 days after quarter end, last 5 times
Dividend
₹1.00 per share · last 23 Jul 2012
2026
  • 7 AugresultsResults · Q1 FY27 · consolidated and standalone-1.1%NSE
  • 21 JulshareholdingShareholding · 30 Jun 20260.0%NSE
  • 30 MayresultsResults · Q4 FY26 · consolidated and standalone-1.9%NSE
  • 20 AprshareholdingShareholding · 31 Mar 2026+0.4%NSE
  • 6 FebresultsResults · Q3 FY26 · consolidated and standalone+0.5%NSE
  • 21 JanshareholdingShareholding · 31 Dec 2025-1.9%NSE

Reaction to results · all yearsrose on day 0 in 23 of 64 CSV

QuarterFiledDay 0+5D+20DRel vol
Q1 FY277 Aug 2026-1.1%-4.9%-3.2%2.0×
Q4 FY2630 May 2026-1.9%-2.2%+0.1%0.7×
Q3 FY266 Feb 2026+0.5%-0.4%-5.4%0.5×
Q2 FY2613 Nov 2025-4.7%+5.8%+0.4%2.3×
Q1 FY2612 Aug 2025-1.0%-2.6%+8.7%0.5×
Q4 FY2530 May 2025-2.4%+6.6%+11.1%2.4×
Q3 FY2515 Feb 2025-8.4%-13.9%-13.6%1.5×
Q2 FY2515 Nov 2024-7.0%-1.7%+10.1%1.3×
Q1 FY2530 Jul 2024-0.2%-5.4%-2.3%0.5×
Q4 FY2431 May 2024+0.6%+5.6%+10.3%1.0×
Q3 FY241 Feb 2024+1.2%+1.3%-15.1%1.1×
Q2 FY2411 Nov 2023-5.4%-6.2%+4.4%0.3×
Q1 FY2412 Aug 2023+6.8%+9.7%+0.8%17.1×
Q4 FY2315 Jul 2023-2.7%-9.1%+1.8%1.6×
Q3 FY2314 Feb 2023-4.5%-7.6%-7.4%1.2×
Q2 FY2315 Nov 2022+2.3%-1.8%+2.1%4.8×
Q1 FY2313 Aug 2022-2.2%-3.1%+12.5%1.5×
Q4 FY2230 May 2022+0.1%+0.3%+1.0%0.4×
Q3 FY2215 Feb 2022+2.9%-13.3%-17.7%1.3×
Q2 FY2214 Nov 2021-4.7%+16.1%-2.8%1.0×
Q1 FY2213 Aug 2021-2.2%-12.6%-3.7%0.7×
Q4 FY2123 Jun 2021-5.0%+5.0%+11.1%0.2×
Q3 FY2113 Feb 2021-6.6%-6.8%+1.4%1.8×
Q2 FY2129 Nov 2020+0.2%-1.4%-4.3%0.6×
Q1 FY211 Oct 2020+8.4%+6.5%+13.2%1.1×
Q4 FY2015 Aug 2020-4.9%+11.2%+0.2%1.1×
Q3 FY2018 Feb 2020+0.7%-3.5%-40.2%2.4×
Q2 FY202 Jan 2020-0.4%-11.2%-7.8%0.1×
Q1 FY2018 Oct 2019-1.5%-2.0%-14.0%0.2×
Q4 FY1923 May 2019-1.0%+3.8%+7.9%0.6×
Q3 FY191 Mar 2019+1.5%+5.0%+12.3%1.8×
Q2 FY1929 Nov 2018+0.1%-4.8%-1.6%0.4×
Q1 FY1928 Aug 2018-0.3%-6.6%-2.6%2.2×
Q4 FY1826 May 2018-1.0%-2.6%-13.0%0.8×
Q3 FY1822 Feb 2018+1.4%-2.2%-3.5%1.0×
Q2 FY1821 Nov 2017-0.6%+3.3%+7.4%0.6×
Q1 FY1821 Aug 2017-0.5%+1.2%+7.1%0.1×
Q4 FY1710 Jun 2017+2.7%+9.1%+1.2%0.9×
Q3 FY1716 Feb 2017-0.2%+7.1%+25.1%0.1×
Q2 FY1717 Nov 2016+0.1%+13.1%+34.9%0.6×
Q1 FY1711 Aug 2016+6.1%+19.4%+8.7%3.4×
Q4 FY1628 May 2016-2.2%-7.3%+10.7%1.1×
Q3 FY1610 Feb 2016-10.6%-14.5%-14.5%0.9×
Q2 FY166 Nov 2015-0.4%-2.8%+3.0%0.6×
Q1 FY1613 Aug 2015+2.4%+9.0%-16.6%0.3×
Q4 FY153 Jun 2015-1.1%-3.4%+1.2%0.6×
Q3 FY152 Feb 2015+0.7%-3.5%+12.1%0.5×
Q2 FY1518 Nov 2014+5.0%-6.2%-6.5%1.2×
Q1 FY1521 Aug 2014-1.2%+1.3%+69.1%0.5×
Q4 FY1422 May 2014-0.6%-17.0%-3.3%0.5×
Q3 FY1421 Feb 2014+4.9%+2.1%+10.6%0.4×
Q2 FY1422 Nov 2013+4.9%-3.5%-12.4%0.1×
Q1 FY1423 Aug 2013+1.6%-7.6%-7.6%0.1×
Q4 FY1318 Jun 20130.0%-11.1%-3.5%0.3×
Q3 FY1325 Feb 2013-4.4%-11.8%-9.1%0.7×
Q2 FY133 Nov 2012+3.2%+3.7%+3.0%1.0×
Q1 FY1310 Aug 2012-1.1%+0.7%0.0%0.4×
Q4 FY1223 May 2012-2.4%0.0%+27.1%0.3×
Q3 FY129 Feb 2012-1.0%-2.2%-10.1%0.4×
Q2 FY1211 Nov 2011-7.9%-17.6%-14.6%0.8×
Q1 FY125 Aug 2011-6.9%-15.2%-2.1%1.1×
Q4 FY117 Jun 2011-0.8%+6.7%-6.3%0.3×
Q3 FY119 Feb 2011-0.9%+18.0%+4.7%1.9×
Q2 FY119 Nov 2010-0.4%-18.3%-38.6%1.3×
Average-0.8%-1.5%+0.5%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q1 FY27

CSV
Revenue YoY+49.7%
Profit YoY-92.5%
Interest cost YoY+524.5%
Revenue QoQ+19.5%
Profit QoQ—
CAGR2Y3Y4Y5Y6Y7Y
Revenue+5.8%——+20.2%——
Profit——————

Key data

CSV
Open277.00
Day range276.00 – 285.85
52-week range252.50 – 363.00
From 52w high-21.5%
RSI (14)43.4
ATR (14)13.67
Volume7.7K
Avg volume (20D)5.8K
Rel volume1.34×
Volatility (1Y)34.2%
Turnover₹22.0L
SMA 50 / 200298.28 / 296.47

Delivery percentage

Latest · 6 Oct 202693.2%
20-day avg80.8%
1-year avg65.8%
Percentile (own history)93rd
Range8.5–100.0%
Sessions1,730

Over the last 20 sessions HEALTHX settled 80.8% of its traded quantity, which is unusually high for an NSE equity. Its one-year average is 65.8%, so recent sessions are running 15.0 points higher than usual. The latest session ranks higher than 93% of the 1,730 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

IndustryHealthcare Service Provider

Performance returns

CSV
1D1W1M3M6M1Y
Price+2.87%-0.07%-2.43%-9.71%+4.90%-9.02%

Valuation

CSV
Market cap₹906 Cr
P/E (TTM)—
EPS (TTM)-8.19
Shares outstanding3.18Cr
Listed5 Oct 2010

Ownership

CSV
Promoter74.07%
Promoter Δ QoQ-0.77 pp
Public25.93%
FII2.29%
DII2.60%
Pledged0.00%

Quarterly results · consolidated

CSV
Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue (₹ Cr)301.3345.7373.8446.8
YoY chg+10.2%+22.9%+30.8%+49.7%
Net profit (₹ Cr)(15.4)0.4(13.0)2.0
YoY chg——-173.8%-92.5%
Net margin-5.1%0.1%-3.5%0.4%
EPS-3.990.35-3.510.80

Shareholding over time

CSV

By quarter

30 Jun 2026 · promoter 74.07% · public 25.93%
30 Sept 2021: promoter 74.43%31 Dec 2021: promoter 73.72%31 Mar 2022: promoter 73.72%30 Jun 2022: promoter 73.92%30 Sept 2022: promoter 73.92%31 Dec 2022: promoter 73.92%31 Mar 2023: promoter 73.92%30 Jun 2023: promoter 73.92%30 Sept 2023: promoter 73.92%31 Dec 2023: promoter 73.92%31 Mar 2024: promoter 73.92%30 Jun 2024: promoter 73.92%30 Sept 2024: promoter 73.92%31 Dec 2024: promoter 73.94%31 Mar 2025: promoter 74.11%30 Jun 2025: promoter 74.24%30 Sept 2025: promoter 74.24%31 Dec 2025: promoter 74.69%31 Mar 2026: promoter 74.84%30 Jun 2026: promoter 74.07%
2021-092026-06
  • Promoter
  • Public and others
Promoter
74.07%
Public
25.93%
Promoter change
-0.77 pp
Filed
21 Jul 2026
FII
2.29%
DII
2.60%
Promoter pledged
0.00%

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.

Financials · quarterly statement

CSV
₹ crore, as filed
 Q2 FY24Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27
Revenue from operations358.5374.5306.7270.3273.5281.3285.8298.4301.3345.7373.8446.8
Other income9.720.118.527.722.3(11.8)21.625.45.513.613.812.8
Total income368.2394.6325.1298.0295.8269.5307.5323.8306.8359.4387.5459.7
Total expenses357.6373.6320.1274.4279.8306.5312.4293.6325.3358.4401.4457.7
└ Finance costs0.20.20.30.10.10.10.00.10.00.20.50.6
└ Depreciation2.22.32.51.61.51.41.31.21.32.21.91.9
Profit before tax10.621.05.024.6(173.6)(39.2)(4.6)30.2(18.6)0.9(14.8)2.0
Tax expense(2.5)0.8(29.2)(25.3)(22.9)0.8(22.2)3.6(3.2)0.6(1.9)(0.0)
Net profit(12.2)(3.2)21.641.0(154.8)(37.8)17.626.6(15.4)0.4(13.0)2.0
EPS-2.55-0.235.179.79-34.40-8.474.307.52-3.990.35-3.510.80
Net margin-3.40%-0.86%7.03%15.16%-56.59%-13.44%6.15%8.91%-5.12%0.11%-3.47%0.44%
PBT margin2.97%5.61%1.63%9.12%-63.48%-13.95%-1.62%10.12%-6.19%0.27%-3.97%0.44%
Tax rate-23.09%3.85%-583.03%-102.77%———11.91%—59.87%—-0.60%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 7 Aug 2026.

HEALTHX at a glance

  • HEALTHX closed at ₹284.95 on 6 Oct 2026, +2.87% on the day, -9.0% over one year, 21.5% below its 52-week high of ₹363.
  • Delivery was 93.2% of traded quantity on 6 Oct 2026, the 93rd percentile of its own 1,730 sessions with a reading (20-session average 80.8%, 1-year average 65.8%).
  • Market capitalisation is ₹906 crore, with no positive trailing earnings for a P/E (trailing EPS ₹-8.19).
  • Q1 FY27 results (consolidated, filed 7 Aug 2026): revenue ₹447 crore (+49.7% year on year), net profit ₹2 crore (-92.5%); the price moved -1.1% on the first session after.
  • Promoters held 74.07% at 30 Jun 2026, down 0.77 percentage points on the previous filing.
  • Q2 FY27 results are expected between 11 Nov 2026 and 15 Nov 2026, going by past filing dates — an estimate, not an announcement.